SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH M impact

Orexo to fund expected US DOJ settlement with rights issue

Orexo flagged an expected settlement payment tied to a matter involving the US Department of Justice, subject to a final settlement agreement. A planned rights issue targets about SEK 250 million, partly to fund the company’s share of the anticipated DOJ settlement.

ORX.ST

Story updates

06:06:14 AM UTC
SquawkNews
Orexo’s board resolved a rights issue of about SEK 250 million, subject to shareholder approval on Nov. 6, 2026. Existing shareholders on Nov. 10, 2026 will receive subscription rights to buy new ordinary shares pro rata. Subscription rights trading is expected Nov. 12—23, 2026; the subscription period is expected Nov. 12—26, 2026. Final terms, including subscription price and subscription ratio, are expected to be announced on Nov. 3, 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Orexo AB published the original content used to generate this news brief on October 06, 2026, and is solely responsible for the information contained therein. (C)
06:06:49 AM UTC
SquawkNews
Orexo’s board resolved, subject to shareholder approval, to launch a rights issue of about SEK 250 million. Proceeds earmarked for OX640’s first pivotal trial through first-half 2027 readout, Izipry regulatory work, platform development, working capital. Funds also allocated to Orexo’s share of an expected U.S. Department of Justice settlement, contingent on a final agreement. Commitments total about SEK 175 million, covering about 70% of the issue, including SEK 16 million subscriptions and SEK 159 million underwriting. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Orexo AB published the original content used to generate this news brief on October 06, 2026, and is solely responsible for the information contained therein. (C)